Luye Pharma Group Ltd. ( LYPHF) - Stock Earnings
LYPHF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q2 | 53.4 million USD | 423.1 million USD |
| 2024Q4 | 11.5 million USD | 409.2 million USD |
| 2025Q2 | 43.7 million USD | 444.0 million USD |
LYPHF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 87.8 million USD | 868.2 million USD |
| 2023 | 75.2 million USD | 867.8 million USD |
| 2024 | 64.6 million USD | 830.4 million USD |
| 2026 Est. | — | — |
LYPHF
Price: $0.33
52 week price:
Earnings Per Share: 0.02 USD
P/E Ratio: 18.88
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.3 billion